Recently I received an email from someone I have never met, who asked me the following:
“Could you refer me to any current study results on Arimidex (Anastrozole)? My oncologist is not helpful. My oncotype dx said I have 9% chance of recurrence and with Arimidex for 5 years that is reduced to 4.5 %. Not sure it is worth it?
I remember being mocked because I wouldn’t take HRT in 1996. He chided me that after my uterus was removed I needed it for my heart. Turns out that was not true. Makes me wonder.
Any current info would be helpful.”
One of the joys of writing for broad audiences is that I get to interact with people outside the worlds of academia and medical practice. And since writing Critical Decisions, I have received an increasing number of emails from people who say the book has helped them through their own medical journeys. On the other hand, that sometimes puts me in the awkward position of trying to figure out how to handle anonymous requests for medical advice… (Read more and view comments at Forbes)